HRTX - Heron Therapeutics EPS in-line beats on revenue August, 05 2019 08:34 AM Heron Therapeutics Inc. Heron Therapeutics (NASDAQ:HRTX): Q2 GAAP EPS of -$0.63 in-line.Revenue of $36.7M (+112.1% Y/Y) beats by $5.27M.Shares +1% PM.Press ReleaseMore news on: Heron Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,